Publication | Open Access
HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer
23
Citations
27
References
2018
Year
Our findings highlight that HJC0152 is a promising therapeutic agent for GC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1